Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05866731 · ClinicalTrials.gov registry record

The Heart Rhythm Twins Study

A clinical trial, sponsored by University of California, San Francisco.

Completed
Registry status
156
Enrollment target

NCT05866731 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 156 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05866731 has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
156 participants
Enrollment target

Study Summary

Premature atrial contractions (PACs) and premature ventricular contractions (PVCs) are observed in the majority of individuals monitored for more than a few hours. Although the clinical course of PACs and PVCs is usually benign, it has been described that high PAC or PVC frequency causes various comorbidities and worsens outcomes in different patient groups. For example, PACs can initiate episodes of atrial fibrillation, and PAC count is highly specific in predicting diagnosis of incident atrial fibrillation. Increasing PVC frequencies are an important predictor of incident heart failure. While conventional wisdom dictates that common environmental exposures determine PAC and PVC frequencies, this has not born out in rigorous studies. Whether PAC and PVC frequencies may have genetic underpinnings remains unknown. Comparisons between identical twins and fraternal twins can provide estimates of heritability. Fraternal twins are an ideal control because, like identical twins, they share a womb, have the same birthday, and their environment while growing up are as similar as between identical twins. However, while identical twins share approximately 100% of the same inherited DNA, fraternal twins share, on average, about 50%. By monitoring identical and fraternal twins with portable electrocardiograms (ECGs), we will be able to count the PACs and PVCs over a consecutive timespan to describe the familial aggregation of these complexes. This, to our knowledge, would be the first study to compare PAC and PVC frequencies in identical and same-sex fraternal twins, providing the first assessment of how genetical inheritance may influence cardiac ectopy burdens.

Trial Details

FieldValue
Enrollment Target 156 participants
Start Date 2022-03-22
Est. Completion 2025-08-18

What the Registry Record Tells You About NCT05866731

The ClinicalTrials.gov registry entry for NCT05866731 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT05866731 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05866731 about?

NCT05866731 is a clinical study titled "The Heart Rhythm Twins Study". Premature atrial contractions (PACs) and premature ventricular contractions (PVCs) are observed in the majority of individuals monitored for more than a few hours. Although the clinical course of PACs and PVCs is usually benign, it has been described that high PAC or PVC frequency causes various com...

What is the current status of trial NCT05866731?

This trial is currently completed. The enrollment target is 156 participants. The study started on 2022-03-22. Estimated completion is 2025-08-18.

Who is sponsoring clinical trial NCT05866731?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.